The Impact of Salsalate Treatment on Serum Levels of Advanced Glycation End Products in Type 2 Diabetes

OBJECTIVE: Salsalate is a nonacetylated salicylate that lowers glucose levels in people with type 2 diabetes (T2D). Here we examined whether salsalate also lowered serum-protein-bound levels of early and advanced glycation end products (AGEs) that have been implicated in diabetic vascular complicati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Barzilay, Joshua I., Jablonski, Kathleen A., Fonseca, Vivian, Shoelson, Steven E., Goldfine, Allison B., Strauch, Christopher, Monnier, Vincent M.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2014
Teme:
Pathophysiology/Complications
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3964486/
https://ncbi.nlm.nih.gov/pubmed/24255104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc13-1527
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki